Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2022.354 | An investigation of air dispersion pattern and the environmental influence of open airway suction in general ward setting and identification of a practical enclosure device for open airway suction in general ward. |
Ms. TO YUK LING 杜玉玲 |
| 2018.159 | Endoscopic retrograde cholangiopancreatography (ERCP) in older patients: is age a risk factor for complications? |
Dr. TO Tsz Yan 杜芷茵 |
| 2018.478 | Situation of idiopathic pulmonary fibrosis in Hong Kong --- a 5 year retrospective epidemiology study |
Dr. TO Kin Wang 杜建宏 |
| 2020.034 | Prospective study to evaluate Stretococcus pneumoniae serotype prevalence in community acquired pneumonia in Hong Kong using a urinary kit |
Dr. TO Kin Wang 杜建宏 |
| 2019.025 | A validation study of a portable monitoring device for diagnosing obstructive sleep apnea in patients with co-existing medical illnesses | Dr. TO Kin Wang |
| 2014.556 | Application of GeneXpert on bronchoscopic samples in the clinical management of patients suspicious of Tuberculosis | Dr. TO Kin Wang |
| 2016.661 | Validation of a novel device for screening patients with symptoms of obstructive sleep apnea |
Dr. TO Kin Wang 杜建宏 |
| 2016.737 | Mortality among Tuberculosis patients in Hong Kong |
Dr. TO Kin Wang 杜建宏 |
| 2013.689 | A cross over case control study using a vibration positional device for treatment of position dependent obstructive sleep apnea | Dr. TO Kin Wang |
| 2011.243 | Defining nasal respiratory tissue biomarkers for diagnosis and monitoring of latent TB in patients with rheumatological diseases. (cross sectional study, with reference to interferon-gamma release assay) | Dr. TO Kin Wang |
| 2012.037 | Comparison of Nasal Positive End Expiratory Pressure valve to dental device as an alternative treatment for OSA | Dr. To Kin Wang |
| 2008.193 | A Cross Sectional Study of Prevalence of Sleep Disordered Breathing in Patients on HAART in a HIV Clinic in Hong Kong | Dr To Kin Wang |
| 2011.109 | A cross sectional study to define the profile of nasal respiratory tissue biomarkers in a different respiratory diseases. |
Dr To Kin Wang 杜建宏 |
| 2009.562 | MicroRNA-mediated regulation of the multidrug resistance transporter ABCG2 | Prof. To Kin Wah |
| 2010.254 | Prognostic value of ABCG2 and its modulation by microRNAs in AML | Professor To Kin Wah |
| 2012.079 | Epigenetic downregulation of the xenobiotic transporter ABCG2 as a predisposing factor for diet-induced colorectal cancer development | Professor To Kin Wah |
| 2012.064 | Epigenetic down-regulation of the xenobiotic transporter ACG2 - a predisposing factor for colorectal cancer development and a novel target for cancer prevention? | Professor To Kin Wah |
| 2010.034 | Clinical relevance of microRNA dysregulation and DNA methylation in mediating overexpression of ABCG2 in chemo-resistant colorectal cancer | Professor To Kin Wah |
| 2013.161 | Xenobiotic transporter ABCG2: Regulatory role in the initiation and progression of colorectal cancer | Professor To Kin Wah |
| 2011.155 | Novel prognostic biomarkers for predicting response to chemotherapy in colorectal cancer | Professor To Kin Wah |
| 2011.034 | Exploiting regulation of the drug transporter ABCG2 for personalized treatment with the HMG-CoA reductase inhibitors (Statins) | Prof. To Kin Wah |
| 2010.398 | Novel prognostic markers for predicting response to chemotherapy in colorectal cancer | Professor To Kin Wah |
| 2013.577 | Identification of genetic and epigenetic biomarkers for the detection of bladder cancer in urine and blood plasma |
Prof. To Ka-Fai 杜家輝 |
| 2014.315 | The effect of educational-based adherence intervention on adherence of inhalation therapy, disease control, quality of life and healthcare utilization among patients with chronic obstructive pulmonary disease: a randomized controlled trial, pilot study | Ms To Ka Wing |
| 2006.133 | Epigenetic Silencing of CXCL14 and Its in Vitro/in Vivo Modulation of Dendritic Cell in Nasopharyngeal Carcinoma | Prof. To Ka Fai |
| 2014.143 | Establishment of a primary cell culture platform of human solid cancers to facilitate molecular and functional studies | Prof. To Ka Fai |
| 2006.278 | Identification of Epstein-Barr Virus miRNA in Nasopharyngeal Carcinoma Cells | Prof. TO Ka Fai |
| 2014.070 | Investigating the genomic landscape of lung cancer | Prof. TO Ka Fai |
| 2014.700 | Study on the role of Esptein-Barr Virus (EBV)-encoded microRNAs in controlling DNA damage repairs in EBV-associated nasopharyngeal carcinoma | Prof. TO Ka Fai |
| 2016.585 | A Multi-Center Retrospective Observational Study to Evaluate PD-L1 Protein Expression in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) |
Prof. TO Ka Fai 杜家輝教授 |
| 2017.096 | Characterization of oncogenic role of BCL3 in Epstein-Barr virus associated nasopharyngeal carcinoma |
Dr. TO Ka Fai 杜家輝 |
| 2014.077 | Hippo signaling/miR-15a and 16 -YAP1-CTGF Regulatory Cascade Promotes Gastric Cancer Progression | Prof To Ka Fai |
| 2016.231 | Target inhibition of ATM-mediated homologous recombination repair by Epstein-Barr virus miR-BARTs in nasopharyngeal carcinoma: molecular mechanisms and clinical implications |
Dr. TO Ka Fai 杜家輝 |
| 2023.625 | The identification of the replication initiation factor MCM10 as a target of YAP1/TEAD4 that drives cancer stemness and drug resistance in gastric cancer | Prof. TO Ka Fai |
| 2024.013 | The identification of complex variants in lung cancer genomes by long-read sequencing | Prof. TO Ka Fai |
| 2020.409 | Molecular signature of different histological subtypes of lung adenocarcinoma | Prof. TO Ka Fai |
| 2020.118 | Developing the next generation sequencing approach to distinguish multiple primary lung cancers from intrapulmonary metastases |
Dr. TO Ka Fai 杜家輝 |
| 2009.521 | Characterization of YAPI as a function oncogene in gastric cancer | Prof. To Ka Fai |
| 2005.129 | Epigenetic Silencing of DOC2-hDAB2 and Tumor Suppressor Activity of DOC2-hDAB2 in Nasopharyngeal Carcinoma | Prof. To Ka Fai |
| 2012.119 | Elucidating the role of tumor suppressive non-coding RNA MEG3 in nasopharyngeal carcinoma | Prof To Ka Fai |
| 2011.140 | Identification the cellular target of Epstein-Barr virus encoded miRNAs in nasopharyngeal carcinoma by RISC immunoprecipitation assay | Prof. To Ka Fai |
| 2009.522 | Characterization of Epstein-Barr virus induced genetic and epigenetic alterations in cholangiocarcinoma cells | Prof. To Ka Fai |
| 2008.167 | Systemic Identification of Epstein-Barr Virus Encoded MicroRNAs Functions in Nasopharyngeal Carcinoma by Integrated Computational and Experimental Approaches | Prof. To Ka Fai |
| 2012.159 | Identification of cancer-specific fusion genes in colorectal cancer | Prof. To Ka Fai |
| 2011.153 | Functional characterization of putative oncogene YAP1 in gastric cancer | Prof To Ka Fai |
| 2009.195 | Targeting Tumor Suppressor DLEC1 by ebv-mir-BART7 and its Role in Carcinogenesis of Nasopharyngeal Carcinoma | Prof. To Ka Fai |
| 2005.174 | Sequencing Analysis of 3' Region of cagA Gene in Helicobacter Pylori Isolated from Hong Kong Chinese Patients with Different H. Pylori-associated Diseases | Prof. TO Ka Fai |
| 2012.020 | Detection of Oncogenic Driver Mutation in Non-small Cell Lung Cancer | Prof. To Ka Fai |
| 2004.152 | Characterization of Epstein Barr Virus Status and Genetic Alterations in Squamous Cell Carcinoma of Nasopharynx and Other Head and Neck Regions | Prof. TO Ka Fai |
| 2011.157 | Transcriptome-wide profiling of microRNA in H. pylori-infected gastric epithelial cells: insight into the host-pathogen interaction | Prof. To Ka Fai |
Page 61 of 289.

